摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-碘苯基)-1H-吡唑 | 368869-86-7

中文名称
1-(4-碘苯基)-1H-吡唑
中文别名
——
英文名称
1-(4-iodophenyl)-1H-pyrazole
英文别名
1-(4-iodo-phenyl)-1H-pyrazole;1-(4-iodophenyl)pyrazole
1-(4-碘苯基)-1H-吡唑化学式
CAS
368869-86-7
化学式
C9H7IN2
mdl
MFCD02681941
分子量
270.072
InChiKey
ADIQBEMLKKKISJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    17.8
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 危险品标志:
    Xi
  • 安全说明:
    S26,S37/39
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2933199090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335
  • 储存条件:
    2-8°C

SDS

SDS:4aa3a1a99c800b9c4b259ec9fa00fbc4
查看
Name: 1-(4-Iodophenyl)-1h-pyrazole 95+% Material Safety Data Sheet
Synonym:
CAS: 368869-86-7
Section 1 - Chemical Product MSDS Name:1-(4-Iodophenyl)-1h-pyrazole 95+% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
368869-86-7 1-(4-Iodophenyl)-1H-pyrazole 95+% unlisted
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 368869-86-7: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: pale yellow
Odor: odorless - slight odor
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 88 - 91 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H7IN2
Molecular Weight: 270.07

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide, hydrogen iodide, iodine.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 368869-86-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-(4-Iodophenyl)-1H-pyrazole - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 368869-86-7: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 368869-86-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 368869-86-7 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(4-碘苯基)-1H-吡唑silver(I) nitrite十二羰基三钌 、 tricyclohexylphosphine tetrafluoroborate 、 [双(三氟乙酰氧基)碘]苯三甲基乙酸 作用下, 以 1,2-二氯乙烷 为溶剂, 反应 24.0h, 以58%的产率得到1-(4-iodo-3-nitrophenyl)-1H-pyrazole
    参考文献:
    名称:
    The ruthenium-catalyzed meta-selective C–H nitration of various azole ring-substituted arenes
    摘要:

    我们开发了一种高效且温和的钌催化的对取代芳烃的唑环进行间位-选择性的CAr–H硝化的方法。

    DOI:
    10.1039/c9ob01930h
  • 作为产物:
    描述:
    potassium 4-(1H-pyrazol-1-yl)phenyltrifluoroboratechloroamine-T 、 sodium iodide 作用下, 以 四氢呋喃 为溶剂, 反应 1.0h, 以90%的产率得到1-(4-碘苯基)-1H-吡唑
    参考文献:
    名称:
    Cu催化的CN偶联反应对有机三氟硼酸盐进行功能化
    摘要:
    通过选择性Cu催化的CN偶联反应成功制备了N-杂二芳基三氟硼酸钾。在 DMSO 存在下,在涉及 CuI 和二甲基乙二胺 (DMEDA) 的反应条件下,BF3K 部分具有良好的耐受性。研究了Pd催化的N-杂二芳基三氟硼酸钾与溴代芳烃的Suzuki-Miyaura交叉偶联制备N-杂三芳基化合物。此外,N-杂二芳基三氟硼酸钾的同源偶联、碘化和羟基化以高产率提供了相应的产物。
    DOI:
    10.5012/bkcs.2013.34.1.42
点击查看最新优质反应信息

文献信息

  • Copper-Catalyzed Arylation of Nitrogen Heterocycles from Anilines under Ligand-Free Conditions
    作者:Dounia Toummini、Anis Tlili、Julien Bergès、Fouad Ouazzani、Marc Taillefer
    DOI:10.1002/chem.201404982
    日期:2014.11.3
    The arylation of pyrazole and derivatives can be achieved by coupling arenediazonium species (formed in situ from anilines) by using a catalytic system that employs low‐toxicity and inexpensive copper metal under very mild and ligand‐free conditions (T=20 °C). From other nitrogen heterocycles, the presence of an additive (NBu4I) significantly improves the efficiency of the catalytic system. These results
    吡唑和衍生物的芳基化反应可以通过使用催化系统偶联槟榔重氮物种(由苯胺原位形成)来实现,该催化系统在非常温和且无配体的条件下(T = 20°C)使用低毒性和廉价的铜金属。与其他氮杂环相比,添加剂(NBu 4 I)的存在可显着提高催化体系的效率。这些结果代表C的第一实施例从芳基重氮物种N键的形成。
  • [EN] AZETIDINES AND CYCLOBUTANES AS HISTAMINE H3 RECEPTOR ANTAGONISTS<br/>[FR] AZÉTIDINES ET CYCLOBUTANES COMME ANTAGONISTES DES RÉCEPTEURS H3 DE L'HISTAMINE
    申请人:EVOTEC NEUROSCIENCES GMBH
    公开号:WO2009135842A1
    公开(公告)日:2009-11-12
    The invention relates to compounds of formula (I) wherein R, R0, R1, m, n and X1 to X4 have the meaning as cited in the description and the claims. Said compounds are useful as Histamine H3 receptor antagonists. The invention also relates to pharmaceutical compositions, the preparation of such compounds as well as the production and use as medicament.
    本发明涉及具有式(I)的化合物,其中R,R0,R1,m,n和X1至X4如描述和权利要求中所引述的含义。所述化合物作为组胺H3受体拮抗剂是有用的。本发明还涉及药物组合物,以及此类化合物的制备以及作为药品的生产和使用。
  • Ligand-free N-arylation of heterocycles using metal–organic framework [Cu(INA)<sub>2</sub>] as an efficient heterogeneous catalyst
    作者:Thanh Truong、Chi V. Nguyen、Ngoc T. Truong、Nam T. S. Phan
    DOI:10.1039/c5ra24165k
    日期:——

    A metal–organic framework [Cu(INA)2] was synthesized and used as a heterogeneous catalyst for arylation of a wide range of N–H heterocycles and aryl halides under ligand-free conditions.

    一种金属有机框架[Cu(INA)2]被合成并用作广泛范围的N-H杂环化合物和芳基卤代物的杂化催化剂,在无配体条件下。
  • From C <sub>1</sub> to C <sub>2</sub> : TMSCF <sub>3</sub> as a Precursor for Pentafluoroethylation
    作者:Qiqiang Xie、Lingchun Li、Ziyue Zhu、Rongyi Zhang、Chuanfa Ni、Jinbo Hu
    DOI:10.1002/anie.201807873
    日期:2018.10
    A highly efficient copper‐mediated aromatic pentafluoroethylation method using TMSCF3 as the sole fluoroalkyl source is described. The reaction proceeds by a key C1 to C2 process, that is, the generation of CuCF3 from TMSCF3, followed by a subsequent spontaneous transformation into CuC2F5. Various aryl iodides were pentafluoroethylated with the TMSCF3‐derived CuC2F5. This method represents the first
    描述了一种高效的铜介导的芳香族五氟乙基化方法,该方法使用TMSCF 3作为唯一的氟代烷基来源。反应的进行通过密钥C 1至C 2的处理,即,CuCF的产生3从TMSCF 3,之后进行随后的自发转变为CUC 2 ˚F 5。各种芳基碘化物都用TMSCF 3衍生的CuC 2 F 5进行了五氟乙基化。该方法代表了使用市售的TMSCF 3作为五氟乙基前体对芳基碘进行五氟乙基化的第一种实用而有效的方法。
  • Transnitrilation from Dimethylmalononitrile to Aryl Grignard and Lithium Reagents: A Practical Method for Aryl Nitrile Synthesis
    作者:Jonathan T. Reeves、Christian A. Malapit、Frederic G. Buono、Kanwar P. Sidhu、Maurice A. Marsini、C. Avery Sader、Keith R. Fandrick、Carl A. Busacca、Chris H. Senanayake
    DOI:10.1021/jacs.5b06136
    日期:2015.7.29
    An electrophilic cyanation of aryl Grignard or lithium reagents, generated in situ from the corresponding aryl bromides or iodides, by a transnitrilation with dimethylmalononitrile (DMMN) was developed. DMMN is a commercially available, bench-stable solid. The transnitrilation with DMMN avoids the use of toxic reagents and transition metals and occurs under mild reaction conditions, even for extremely
    开发了芳基格氏试剂或锂试剂的亲电氰化,由相应的芳基溴化物或碘化物原位生成,通过与二甲基丙二腈 (DMMN) 进行腈基转移。DMMN 是市售的、工作台稳定的固体。使用 DMMN 进行的腈基转移避免了使用有毒试剂和过渡金属,并且在温和的反应条件下发生,即使对于空间位阻非常大的底物也是如此。由定向邻位锂化产生的芳基锂物质的腈基转腈作用使净 CH 氰化成为可能。Thorpe 型亚胺加合物在反应中的中介作用是通过从淬灭反应中分离相应的酮来支持的。计算研究支持亚胺加合物逆向索普碎裂的能量有利性。
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺